Long term mortality of patients with Parkinson's disease treated with deep brain stimulation in a reference center - ScienceDirect

Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial - The Lancet

Clinical characteristics of patients with Parkinson's disease (PD)

Frontiers The mortality of patients with Parkinson's disease with deep brain stimulation

Deep brain stimulation of the subthalamic nucleus in Parkinson's disease after 15 years: Clinical outcome and caregiver burden - Deep Brain Stimulation

Deletions at 22q11.2 in idiopathic Parkinson's disease: a combined analysis of genome-wide association data - The Lancet Neurology

Parkinson's disease - The Lancet

Continuous intestinal infusion of levodopa–carbidopa in patients with advanced Parkinson's disease in Spain: Subanalysis by autonomous community

The mortality of patients with Parkinson's disease with deep brain stimulation - Frontiers

Clinical outcome of deep brain stimulation for Parkinson's disease - ScienceDirect